Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Sullivan Timothy Eugene Create: Alert

All | News | Filings
Date FiledTypeDescription
07/06/2023 4 Sullivan Timothy Eugene (CFO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Sold 3,192 shares @ $89.4109, valued at $285.4k
Sold 3,287 shares @ $90.4165, valued at $297.2k
Sold 300 shares @ $91.0983, valued at $27.3k
Exercised 6,779 options to buy @ $10.03, valued at $68k
06/06/2023 4 Sullivan Timothy Eugene (CFO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Sold 1,600 shares @ $90.6044, valued at $145k
Sold 30,609 shares @ $87.7886, valued at $2.7M
Sold 7,064 shares @ $88.3649, valued at $624.2k
Sold 30,506 shares @ $89.8259, valued at $2.7M
Exercised 69,779 options to buy @ $10.03, valued at $699.9k
05/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/22/2023 4 Sullivan Timothy Eugene (CFO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Granted 11,683 shares @ $0
Paid exercise price by delivering 974 shares @ $58.5, valued at $57k
Granted 16,572 options to buy @ $35.46, valued at $587.6k
02/14/2023 4 Sullivan Timothy Eugene (CFO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 975 shares @ $51.21, valued at $49.9k
01/30/2023 4 Sullivan Timothy Eugene (CFO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 551 shares @ $52.77, valued at $29.1k
01/24/2023 4 Sullivan Timothy Eugene (CFO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 2,379 shares @ $52.05, valued at $123.8k
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2022 4 Sullivan Timothy Eugene (CFO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 650 shares @ $38.59, valued at $25.1k
01/25/2022 4 Sullivan Timothy Eugene (CFO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Granted 30,787 shares @ $0
Granted 43,670 options to buy @ $35.46, valued at $1.5M
06/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/12/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/03/2019 4 Sullivan Timothy Eugene (CFO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Bought 11,699 shares @ $29.7145, valued at $347.6k
02/12/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/21/2018 4 Sullivan Timothy Eugene (CFO) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Granted 25,000 options to buy @ $14.95, valued at $373.8k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy